Search clinical trials for: MAGE-C2

Total 2417 results

Erasmus Medical Center
Ludwig Institute for Cancer Research; Dutch Cancer Society; Stichting Coolsingel... and other collaborators

Recruiting

MAGE-C2 TCR T Cell Trial to Treat Melanoma and Head and Neck Cancer (MC2TCR)

Melanoma | Head and Neck Cancer | Melanoma, Uveal

Netherlands
University Hospital, Toulouse

Completed

Combined Deep Brain Stimulation in Parkinson's Disease (SCP-FOG)

Parkinson Disease

France
TScan Therapeutics, Inc.

Recruiting

A Screening Study to Collect Samples for TAA, HLA & HLA Loss of Heterozygosity in Patients With Metastatic Solid Tumors

Melanoma | Cervical Cancer | Head and Neck Cancer | Ovarian Cancer | Non Small Cell Lung Cancer | HPV16 Related Cancers

United States
Pierre Fabre Medicament
Eurotrials Brasil Consultores Cientificos Ltda

Withdrawn

EXPLORATORY ASSESSMENT OF THE EFFECTS OF CYCLO 3 ® FORT (Ruscus Extract, Hesperidin Methyl Chalcone, Ascorbic Acid) OR MICRONISED PURIFIED FLAVONOID FRACTION ON VASCULAR PARAMETERS AND BIOMARKERS IN WOMEN SUFFERING FROM CHRONIC VENOUS DISEASE (CEAP C2 OR C3), OVER 8 WEEKS

Venous Disease Classification (CEAP): C2 or C3
University of Arkansas

Completed

Study of MAGE-A3 and NY-ESO-1 Immunotherapy in Combo With DTPACE Chemo and Auto Transplantation in Multiple Myeloma

Multiple Myeloma

United States
Charite University, Berlin, Germany

Unknown

Multiepitope Peptide Vaccination in Melanoma

Metastatic Melanoma

Germany
Karolinska University Hospital
Experimental Asthma and Allergy Research Unit, Karolinska Institutet; Unit... and other collaborators

Terminated

Pemirolast in Allergen Challenge (PEMAG) (PEMAG)

Allergic Asthma

Sweden
Penn State University

Withdrawn

A Vaccine Study for High Risk Cancers

Neuroblastoma | Osteogenic Sarcoma | Rhabdomyosarcoma
Erasme University Hospital

Completed

MAgnetic Gastrointestinal Universal Septotome: a Safety and Feasibility Study (MAGUS) (MAGUS)

Diverticulum, Esophageal | Post Gastric Surgery Syndrome

Belgium
Canadian Cancer Trials Group
Ottawa Hospital Research Institute

Active, not recruiting

MG1 Maraba/MAGE-A3, With and Without Adenovirus Vaccine With Transgenic MAGE-A3 Insertion in Incurable MAGE-A3-Expressing Solid Tumours

Advanced/Metastatic Solid Tumours

Canada
Adaptimmune

Active, not recruiting

MAGE-A4ᶜ¹º³²T for Multi-Tumor

Melanoma | Head and Neck Cancer | Gastric Cancer | Esophageal Cancer | Ovarian Cancer | Non-Small Cell Lung Cancer | Urinary Bladder Cancer | Synovial Sarcoma | Gastroesophageal Junction | Myxoid Round Cell Liposarcoma

United States, Canada
M.D. Anderson Cancer Center

Completed

Tumor and Vaccine Site With a Toll Like Receptor (TLR) Agonist

Melanoma

United States
Fatih Sultan Mehmet Training and Research Hospital

Completed

TISSUE SHRINKAGE DEPENDS ON FORMOL SOLUTION IN DIFFERENT GASTRIC LOCATIONS (SHRINKAGE)

Shrinking Stomach

Turkey
Pentax Medical

Completed

Efficacy of CryoBalloon Focal Ablation System on Human Esophageal Barrett's Epithelium

Barrett's Esophagus

Netherlands
Mage Biologics
Alimentiv Inc.

Recruiting

A Phase 1 Study to Evaluate the Safety of an Oral Biologic in Healthy Participants

Ulcerative Colitis

Australia
University of Chicago

Completed

Study of MAGE-3/Melan-A/gp 100/NA17 and rhIL-12 With/Out Low Dose IL-2 in Metastatic Melanoma

Metastatic Melanoma

United States
GlaxoSmithKline

Completed

Study of GSK2132231A Antigen-Specific Cancer Immunotherapeutic in Patients With Inoperable Metastatic Cutaneous Melanoma

Melanoma

France, Belgium
University Hospital, Ghent
European Venous Forum.; Benelux Society of Phlebology.

Completed

Prospective Multicentric Trial Between Radiofrequency Ablation With VNUS Closure Fast ® and Endovenous Ablation With 1470 nm Diode Laser and Tulip Fiber ® for Treatment of Primary Venous Insufficiency. (VNUS vs TULIP)

Chronic Venous Insufficiency C2 or Higher

Belgium
Shockwave Medical, Inc.

Completed

Disrupt CAD III Post-Approval Study (PAS)

Myocardial Infarction | Coronary Artery Disease

United States
Massachusetts General Hospital
National Center for Complementary and Integrative Health (NCCIH)

Active, not recruiting

Live Video Mind-body Treatment to Prevent Persistent Symptoms Following mTBI

Anxiety | MTBI - Mild Traumatic Brain Injury

United States
Boehringer Ingelheim

Not yet recruiting

A Study in Healthy People to Compare How 2 Different High Dose Formulations of BI 1015550 Are Taken up in the Body

Healthy
GlaxoSmithKline

Completed

A Study to Test the Benefit of a New Anti-cancer Treatment in Patients With Unresectable Advanced Melanoma (PREDICT)

Melanoma

United States, Spain, Germany, France, Poland, Italy, Ireland, Russian Federation
Novartis Pharmaceuticals

Completed

Cyclosporine A C-2h Monitoring Versus Tacrolimus C-0h Monitoring in de Novo Liver Transplant Recipients

Liver Transplant

Switzerland
AstraZeneca

Completed

C2 -CORVUS Cholesterol-Control (C2) Controlled Targets for High Vascular Risk Patients Using Effective Statins (CORVUS) (C2 -CORVUS)

Cardiovascular Risk

Hungary
Pentax Medical

Not yet recruiting

C2 Esophageal Squamous Epithelium Dysplasia

Esophageal Squamous Epithelium Dysplasia

China
Centre Hospitalier Universitaire Vaudois
Ludwig Institute for Cancer Research

Completed

Immunotherapy of Stage III/IV Melanoma Patients

Melanoma

Switzerland
Sohag University

Completed

Surgical Outcome of Type II Odontoid Fracture, Harms Technique

Tramatic Odontoid Fracture

Egypt
Adaptimmune

Completed

MAGE-A10ᶜ⁷⁹⁶T for Urothelial Cancer, Melanoma or Head and Neck Cancers

Melanoma | Head and Neck Cancer | Urothelial Carcinoma | Bladder Urothelial Carcinoma

United States, Canada, Spain
Tianjin Medical University Cancer Institute and...

Unknown

Clinical Safety and Preliminary Efficacy of MAGE-A4 TCR Gene-Modified T Cells to Treat Malignant Tumors

Malignant Solid Tumors

China
Peking University
Shanghai Ming Ju Biotechnology Co., Ltd.

Recruiting

MAGE-A4-directed TCR-T in the Treatment Amongst Subjects With Advanced Solid Tumors

Advanced Solid Tumor

China
David Lunardini
University of Vermont

Recruiting

PTH Analog Type II Odontoid Fracture

Odontoid Fracture

United States
Texas Tech University

Completed

Web Based Intervention to Reduce Weight Bias Among Dietitians

Intervention Video (I) | Weight Control Video (C1) | Weight Neutral Control Video (C2)

United States
KU Leuven

Suspended

Telemonitoring of Hypertensive Patients (LAPTOHP)

Hypertension

Belgium
Immunocore Ltd

Terminated

Safety and Efficacy of IMC-C103C as Monotherapy and in Combination With Atezolizumab

Select Advanced Solid Tumors

United States, United Kingdom, Spain
T-knife GmbH

Terminated

A Phase 1/ 2, First-in-Human, Open-Label, Accelerated-Titration, Two-Part Clinical Trial of TK-8001 in Patients With HLA-A*02:01 Genotype and Advanced-Stage/ Metastatic MAGE-A1+ Solid Tumors (IMAG1NE)

Advanced Solid Tumors

Germany, Belgium, Spain, Netherlands, United Kingdom
University of Maryland, Baltimore
National Institute of Dental and Craniofacial Research (NIDCR)

Completed

0804 GCC: MAGE-A3/HPV 16 Vaccine for Squamous Cell Carcinoma of the Head and Neck

Squamous Cell Carcinoma of the Head and Neck

United States
Rothman Institute Orthopaedics

Unknown

Randomized, Controlled Trial of Posterior C1-2 Fusion Versus Bracing Alone for Treatment of Type II Odontoid Process Fractures in the Elderly

Odontoid Fracture

United States
Imperial College London

Completed

The Effect of Macronutrients on Satiety and Gut Hormone Responses (Microcapsule)

Eating Behavior

Ireland
Ludwig Institute for Cancer Research

Terminated

Immunization With the MAGE-3.A1 Peptide Mixed With the Adjuvant CpG 7909 in Patients With Metastatic Melanoma

Malignant Melanoma

Belgium
KU Leuven

Unknown

The Use of a Non-absorbable Marker for the Evaluation of the Gastrointestinal Transit

Concentration-Time Profiles in Stomach & Intestine.

Belgium
Patrice Jichlinski
GlaxoSmithKline; Ludwig Center for Cancer Research of Lausanne

Completed

BCG Modulation of the recMAGE-A3 + AS15 ASCI Response in the Treatment of Non Muscle Invasive Bladder Cancer (NMIBC) Patients

Bladder Cancer

Switzerland
Columbia University

Recruiting

Gastric Emptying in Neonates and Infants After Formula Feeding

Gastric Emptying

United States
Prince of Wales Hospital, Shatin, Hong Kong

Completed

Gastric Ultrasound Prior to Extubation

Fasting

Hong Kong
feng Zheng

Unknown

Roux-en-Y Versus Billroth II Reconstruction After Subtotal Gastrectomy in Gastric Cancer Comorbid With Type II Diabetes

Gastric Cancer | Type 2 Diabetes

China
Oslo University Hospital
Diakonhjemmet Hospital; Sykehuset Telemark; Helse Forde; Sykehuset Ostfold; Sykehuset... and other collaborators

Completed

Displaced Proximal Humeral Fractures: Delta Prothesis or Philos Plate? (DELPHI)

Proximal Humeral Fractures, AO/OTA (2007) Group B2 and C2

Norway
University Hospital, Clermont-Ferrand
Stryker SA; Polyclinique du Parc Rambot

Completed

Metaphyseal Distal Radius Fractures

Metaphyseal Radius Fractures (AO Type A2, A3, C1 et C2)

France
Assiut University

Unknown

Conventional VS Enhanced Recovery After Surgery Protocols in Emergency GIT Surgery

Patient Presented With Acute Abdomen | Patient Undergoing Urgent GIT Surgery
Meddoc
Meabco A/S

Recruiting

Recommended Dose Estimation of BP-C2

Prostate Cancer

Norway
Genesis Medtech Corporation

Active, not recruiting

SOLSTICE Trial in China

Coronary Artery Disease | Calcifications Vascular

China
Weill Medical College of Cornell University

Withdrawn

Comparison of Global, G-TL, & Cornell Media

Infertility

United States

Search clinical trials for: MAGE-C2

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Saint Lucia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations